Skip to main content

Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) Investor Investigation Concerning Potential Securities Laws Violations Announced

  • If you purchased shares of Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

October 21, 2013 (Shareholders Foundation) - An investigation on behalf of investors of Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPR) shares over potential securities laws violations by Catalyst Pharmaceutical Partners, Inc. and certain of its directors and officers in connection certain statements over its drug Firdapse was announced. The investigation by a law firm focuses on ...



You must register (for free) or login to view the entire investigation.